Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
These phrases are wellness marketing shorthand, not a defined chemical product
Int J Molec Sci 2024;25:5209
Systematic reviews and meta-analyses of randomised controlled trials suggest that berberine may modestly reduce fasting blood glucose, HbA1c (a marker of long-term glucose control), and post-meal glucose levels in people with type 2 diabetes or non-diabetic hyperglycaemia (prediabetes)
YP05002 and Pipeline Strategy YP05002 is a small-molecule GLP-1 agonist that Yao Pharma has indicated has therapeutic potential beyond weight loss, including in conditions such as diabetes and metabolic dysfunction-associated steatohepatitis (MASH)
Additional Information Good to Know It helps provide nourishment to the skin
A 2024 meta-analysis found GLP-1 receptor agonists helped lower BMI, waist circumference, triglycerides, and total testosterone in women with PCOS living with obesity
US$ 26.27
US$ 27.11
US$ 24.18
US$ 22.30
US$ 28.60
US$ 24.46
US$ 21.90
US$ 28.53
